A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran
暂无分享,去创建一个
Johan Lindberg | Raji Balasubramanian | Ina Schuppe-Koistinen | Ulf Andersson | J. Lindberg | R. Balasubramanian | U. Andersson | K. Nilsson | I. Schuppe-Koistinen | J. Kolmert | P. Juhasz | L. Nord | Chenhui Zeng | B. Glinghammar | Shunghuang Wang | Maritha Marcusson-Ståhl | Mira Hannula | Peter J. Juhasz | Johan Kolmert | Jonas Bäckström | Lars Nord | Kerstin Nilsson | Steve Martin | Björn Glinghammar | Karin Cederbrant | Jonas Bäckström | K. Cederbrant | Steve Martin | M. Marcusson-Ståhl | Chenhui Zeng | Shunghuang Wang | M. Hannula | Steve Z. Martin | Maritha Marcusson-Ståhl
[1] A Jawaid,et al. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis , 2008, The Pharmacogenomics Journal.
[2] P. Beaune,et al. Prediction of drug-induced liver injury in humans by using in vitro methods: the case of ximelagatran. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.
[3] W. Kwon,et al. Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats , 2008, Human & experimental toxicology.
[4] J. van der Greef,et al. The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.
[5] F. Guo,et al. The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. , 2007, Cell metabolism.
[6] D. Durden,et al. Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase* , 2006, Journal of Biological Chemistry.
[7] M. Speeckaert,et al. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[8] E. Hinoi,et al. A Molecular Mechanism of Pyruvate Protection against Cytotoxicity of Reactive Oxygen Species in Osteoblasts , 2006, Molecular Pharmacology.
[9] E. Stanley,et al. Colony-stimulating factor-1 in immunity and inflammation. , 2006, Current opinion in immunology.
[10] T. Hankemeier,et al. Microbial metabolomics with gas chromatography/mass spectrometry. , 2006, Analytical chemistry.
[11] M. Holness,et al. Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases , 2006, Archives of physiology and biochemistry.
[12] P. Lenting,et al. In Vivo Clearance of Human Protein S in a Mouse Model: Influence of C4b-Binding Protein and the Heerlen Polymorphism , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[13] B. Bucher,et al. Ethyl Pyruvate Ameliorates Liver Ischemia-Reperfusion Injury by Decreasing Hepatic Necrosis and Apoptosis , 2005, Transplantation.
[14] William M. Lee,et al. Hepatic Findings in Long-Term Clinical Trials of Ximelagatran , 2005, Drug safety.
[15] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[16] A. Blom,et al. The C4b-binding Protein-Protein S Complex Inhibits the Phagocytosis of Apoptotic Cells* , 2004, Journal of Biological Chemistry.
[17] D. Naisbitt,et al. A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals. , 2004, Toxicology.
[18] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[19] Matej Oresic,et al. Methods for the differential integrative omic analysis of plasma from a transgenic disease animal model. , 2004, Omics : a journal of integrative biology.
[20] G. Olsson,et al. The statin wars , 2003, The Lancet.
[21] S. Olsson,et al. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial , 2003, The Lancet.
[22] R. Andrade,et al. Drug-induced hepatotoxicity , 2003, The New England journal of medicine.
[23] M. Wolzt,et al. Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects , 2003, European Journal of Clinical Pharmacology.
[24] C. Paweletz,et al. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells , 2003, Nature Immunology.
[25] S. Kimball,et al. The GCN2 eIF2α Kinase Is Required for Adaptation to Amino Acid Deprivation in Mice , 2002, Molecular and Cellular Biology.
[26] A. Blom,et al. Vitamin K-Dependent Protein S Localizing Complement Regulator C4b-Binding Protein to the Surface of Apoptotic Cells1 , 2002, The Journal of Immunology.
[27] Geoffrey J McLachlan,et al. Selection bias in gene extraction on the basis of microarray gene-expression data , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[28] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[29] R. Ulrich,et al. Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. , 2001, Chemico-biological interactions.
[30] M. Cynader,et al. Pyruvate Released by Astrocytes Protects Neurons from Copper-Catalyzed Cysteine Neurotoxicity , 2001, The Journal of Neuroscience.
[31] Rocco Vivenzio. Geriatrics Review Syllabus: A Core Curriculum in Geriatric Medicine , 2001, Annals of Internal Medicine.
[32] P. Taylor,et al. A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo , 2000, The Journal of experimental medicine.
[33] R. Mallet. Pyruvate: metabolic protector of cardiac performance. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[34] D. Hume,et al. Bacterial/CpG DNA down-modulates colony stimulating factor-1 receptor surface expression on murine bone marrow-derived macrophages with concomitant growth arrest and factor-independent survival. , 1999, Journal of immunology.
[35] S. Valitutti,et al. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. , 1998, The Journal of clinical investigation.
[36] J. Glowinski,et al. Pyruvate Protects Neurons against Hydrogen Peroxide-Induced Toxicity , 1997, The Journal of Neuroscience.
[37] L. Nencioni,et al. Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. , 1996, Cytokine.
[38] R. Ulrich,et al. Potentiation of hypoxic injury in cultured rabbit hepatocytes by the quinoxalinone anxiolytic, panadiplon. , 1996, Toxicology.
[39] H. Lange,et al. The effect of erythropoietin on lactate, pyruvate and excess lactate under physical exercise in dialysis patients. , 1996, Clinical nephrology.
[40] W. M. Lee,et al. Drug-induced hepatotoxicity. , 1995, The New England journal of medicine.
[41] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[42] C. Nathan,et al. Secretion of pyruvate. An antioxidant defense of mammalian cells , 1987, The Journal of experimental medicine.
[43] P. Felig,et al. Substrate, hormone, and temperature responses in males and females to a common breakfast. , 1980, Metabolism: clinical and experimental.
[44] P. Srere. The citrate enzymes: their structures, mechanisms, and biological functions. , 1972, Current topics in cellular regulation.
[45] A. Wald. Note on the Consistency of the Maximum Likelihood Estimate , 1949 .
[46] W. James,et al. Malnutrition , 1916, The Hospital.